A carregar...
Therapeutic strategies and mechanisms of tumorigenesis of HER2-overexpressing breast cancer
The receptor tyrosine kinase HER2 is overexpressed in approximately 25% of breast cancers. HER2 acts as a signal amplifier for its siblings, namely three different transmembrane receptors that collectively bind with 11 distinct growth factors of the EGF family. Thus, overexpression of HER2 confers a...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3038194/ https://ncbi.nlm.nih.gov/pubmed/20951604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.critrevonc.2010.09.002 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|